1,191 reports of this reaction
3.3% of all INTERFERON BETA 1B reports
#4 most reported adverse reaction
FATIGUE is the #4 most commonly reported adverse reaction for INTERFERON BETA 1B, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 1,191 FDA adverse event reports linking INTERFERON BETA 1B to FATIGUE. This represents approximately 3.3% of all 36,175 adverse event reports for this drug.
Patients taking INTERFERON BETA 1B who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among INTERFERON BETA 1B users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for INTERFERON BETA 1B:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,191 FDA reports for INTERFERON BETA 1B. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.3% of all adverse event reports for INTERFERON BETA 1B, making it a notable side effect.
If you experience fatigue while taking INTERFERON BETA 1B, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.